What actually works. What doesn't.
The two longest-term consequences of the menopause transition aren't on the symptom list women are warned about. Bone density falls fastest in the years around the final period. Cardiovascular risk diverges from men's. The interventions that genuinely change those trajectories are not the ones being sold on Instagram.
Why bone loss accelerates around the final menstrual period and what the evidence says about preventing it — resistance training, adequate protein and calcium, vitamin D where deficient, and the role of hormone therapy and bone-specific medications. Why women's cardiovascular risk profile changes at midlife, what the AHA's 2020 menopause-and-CVD statement actually says, and which midlife symptoms (like frequent vasomotor symptoms) flag higher future CVD risk.
Sell you a calcium-magnesium-K2 megadose, a 'bone broth protocol,' or a heart-health supplement. Replace a DEXA scan or a lipid panel. Promise that any single intervention prevents fracture or heart disease. Every recommendation here will be sourced to peer-reviewed evidence and major society guidelines; every author named; every reviewer board-certified. Read our editorial standards →
Articles in this guide are coming soon. In the meantime, explore the related clusters below.